Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial (Q34141305)
Jump to navigation
Jump to search
scientific article published on October 2, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial |
scientific article published on October 2, 2010 |
Statements
1 reference
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial (English)
1 reference
M. Hallek
P. L. Zinzani
International Group of Investigators
1 reference
German Chronic Lymphocytic Leukaemia Study Group
1 reference
K. Fischer
G. Fingerle-Rowson
A. M. Fink
R. Busch
J. Mayer
M. Hensel
G. Hopfinger
G. Hess
U. von Grünhagen
M. Bergmann
J. Catalano
F. Caligaris-Cappio
J. F. Seymour
A. Berrebi
U. Jäger
B. Cazin
A. Westermann
C. M. Wendtner
B. F. Eichhorst
P. Staib
A. Bühler
D. Winkler
T. Zenz
S. Böttcher
M. Ritgen
M. Mendila
M. Kneba
H. Döhner
1 October 2010
1 reference
1 reference
376
1 reference
9747
1 reference
1164-1174
1 reference
Identifiers
1 reference
1 reference